MEDME: An experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 4.
Figure 4.

Validation with bisulfite genomic DNA sequencing. Promoter methylation status in 14 genes are determined by bisulfite sequencing and compared with the AMS (A, Y-axis) and RMS (B, Y-axis) on both NBMEL and YUSAC2 samples. AMS and RMS refer here to the average for the probes within the amplicon used for bisulfite genomic DNA sequencing. Weighted MeDIP logR (MeDIPw), absolute (AMS) and relative (RMS) measurement of methylation level in ARMCX2 promoter (C) and ZIC3 promoter (D) are shown. Gray lines indicate the regions analyzed by bisulfite genomic DNA sequencing. CpGr indicates the CpG ratio for each probe (for details, see Methods). Bisulfite sequencing of differentially methylated ARMCX2 promoter (E) and ZIC3 promoter (F) are shown. Each line represents the sequence of a single clone. CpGs are represented as open dots (if unmethylated) or filled dots (if methylated). The percentage of CpG methylation is indicated for each amplicon.

This Article

  1. Genome Res. 18: 1652-1659

Preprint Server